These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1352109)

  • 61. An analysis of the use of dogs in predicting human toxicology and drug safety.
    Bailey J; Thew M; Balls M
    Altern Lab Anim; 2013 Nov; 41(5):335-50. PubMed ID: 24329742
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Safety evaluation of biological drugs: what are toxicology studies in primates telling us?
    Baldrick P
    Regul Toxicol Pharmacol; 2011 Mar; 59(2):227-36. PubMed ID: 20937341
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regulatory forum opinion piece*: reversibility groups: the "hows" and "how-nots".
    Ochoa R
    Toxicol Pathol; 2013; 41(3):552-3. PubMed ID: 22821368
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 65. NTP Toxicology and Carcinogenesis Studies of Nickel Oxide (CAS No. 1313-99-1) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Jul; 451():1-381. PubMed ID: 12594524
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recommendations for safety pharmacology evaluations of oligonucleotide-based therapeutics.
    Berman CL; Cannon K; Cui Y; Kornbrust DJ; Lagrutta A; Sun SZ; Tepper J; Waldron G; Younis HS
    Nucleic Acid Ther; 2014 Aug; 24(4):291-301. PubMed ID: 24946015
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Juvenile animal testing in drug development--is it useful?
    Baldrick P
    Regul Toxicol Pharmacol; 2010; 57(2-3):291-9. PubMed ID: 20350578
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The timing of preclinical toxicological studies: pharmaceutical company approaches to toxicity testing in support of initial clinical investigations.
    Parkinson C; Thomas KE; Lumley CE
    Regul Toxicol Pharmacol; 1996 Apr; 23(2):162-72. PubMed ID: 8661335
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nonclinical proarrhythmia models: predicting Torsades de Pointes.
    Lawrence CL; Pollard CE; Hammond TG; Valentin JP
    J Pharmacol Toxicol Methods; 2005; 52(1):46-59. PubMed ID: 15975832
    [TBL] [Abstract][Full Text] [Related]  

  • 70. NTP technical report on the toxicity studies of Isoprene (CAS No. 78-79-5) Administered by Inhalation to F344/N Rats and B6C3F1 Mice.
    Melnick R
    Toxic Rep Ser; 1995 Jan; 31():1-G5. PubMed ID: 12209193
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Animal toxicology studies on new medicines and their relationship to clinical exposure: a review of international recommendations.
    Scales MD; Mahoney K
    Adverse Drug React Toxicol Rev; 1991; 10(3):155-68. PubMed ID: 1747442
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tricontinental agreement on less toxicology.
    Ann Oncol; 1992 Jun; 3(6):412-3. PubMed ID: 1498055
    [No Abstract]   [Full Text] [Related]  

  • 73. Relevance of the 1-year dog study in assessing human health risks for registration of pesticides. An update to include pesticides registered in Japan.
    Kobel W; Fegert I; Billington R; Lewis R; Bentley K; Langrand-Lerche C; Botham P; Sato M; Debruyne E; Strupp C; van Ravenzwaay B
    Crit Rev Toxicol; 2014 Nov; 44(10):842-8. PubMed ID: 25198386
    [TBL] [Abstract][Full Text] [Related]  

  • 74. NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 427():1-275. PubMed ID: 12616304
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety evaluation to support First-In-Man investigations II: toxicology studies.
    Baldrick P
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):237-43. PubMed ID: 18501490
    [TBL] [Abstract][Full Text] [Related]  

  • 76. NTP Toxicology and Carcinogenesis Studies of t-Butylhydroquinone (CAS No. 1948-33-0) in F344/N Rats and B6C3F(1) Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 459():1-326. PubMed ID: 12587017
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Part 2. Assessment of micronucleus formation in rats after chronic exposure to new-technology diesel exhaust in the ACES bioassay.
    Bemis JC; Torous DK; Dertinger SD;
    Res Rep Health Eff Inst; 2015 Jan; (184):69-82; discussion 141-71. PubMed ID: 25842616
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Introducing the concept of virtual control groups into preclinical toxicology testing.
    Steger-Hartmann T; Kreuchwig A; Vaas L; Wichard J; Bringezu F; Amberg A; Muster W; Pognan F; Barber C
    ALTEX; 2020; 37(3):343-349. PubMed ID: 32242633
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A Historical View and Vision into the Future of the Field of Safety Pharmacology.
    Bass AS; Hombo T; Kasai C; Kinter LB; Valentin JP
    Handb Exp Pharmacol; 2015; 229():3-45. PubMed ID: 26091634
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An analysis of the use of animal models in predicting human toxicology and drug safety.
    Bailey J; Thew M; Balls M
    Altern Lab Anim; 2014 Jun; 42(3):181-99. PubMed ID: 25068930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.